Overweight
Conditions
Keywords
blood cholesterol, blood lipid profile, triglycerides, commercial pills, fish oil, lipid peroxidation, Circulating lipidic profile
Brief summary
The oxidation level of unsaturated fatty acid supplements commercialized in capsules could be a serious problem for manufacturers and a risk to consumers; health by ingesting substances whose effects are not desired. Therefore, the main objective of this paper is to analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose the investigators have designed a single-blind, parallel-groups, randomized controlled trial. Finally, 52 women between 25 and 75 years old were randomly distributed into three groups: (1) took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet, (2) took 2 capsules/day of one of the most oxidized oil (containing 300 mg EPA + DHA) and diet and (3) no capsules, only received the diet. There was a 30 days follow-up . All groups followed a low cholesterol diet. Circulating glucose, total cholesterol, triglycerides and glutamic pyruvic transaminase were determined at the beginning and end of a 30 day period.
Detailed description
The assignment of women to distinct groups was carried out following the classification criteria established by (NCEP, 2002), and performed by the research team. Women were randomly assigned to one of three parallel groups, in a near 1:1:1 ratio. Group 1 (n=20) took two capsules per day of less oxidized oil (containing 300 mg EPA-DHA per capsule) and diet. Group 2 (n=18) consumed two capsules per day of oxidized oil (containing 300 mg EPA-DHA per capsule) and diet. Finally, group 3 (n=19) performed the diet but did not take any capsule. Therefore, the design was a single-blind (participants did not know what type of capsule they were receiving), parallel-group, randomized controlled trial conducted at the Miguel Hernández University of Elche (Spain). Statistical analysis was carried out using STATGRAPHICS Centurion XV software (StatPoint Technologies, Inc. Warrington, VA); likewise, significance was defined at p\<0.05. Data are reported as mean standard error of the mean (SEM). Intragroup statistical comparisons were performed using the following hypothesis tests, both parametric and non-parametric: t-test, sign test and signed rank test for paired samples. Intergroup statistical comparisons were performed using the one-way analysis of variance (ANOVA) and the Kruskal-Wallis hypothesis tests. Also, Fisher least significant difference (LSD)Multiple Range Test and Tukey HSD were used in order to determine which means were significantly different from the others. Methods for additional analyses Generalized multiple regression was used to statistically analyse the relationships between the variations in the lipid profile and the consumption of w-3 dietary supplements.
Interventions
DIETARY_SUPPLEMENTLess oxidized oil and diet
Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet, . Follow-up 30 days
DIETARY_SUPPLEMENTMore oxidized oil and diet
Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet . Follow-up 30 days
DRUGHypercholesterolemic diet
Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 3 only received the diet and no capsules. Follow-up 30 days
Sponsors
Instituto de Salud Carlos III
University of Alicante
Universidad Miguel Hernandez de Elche
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
FEMALE
Age
25 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* presence of dyslipemia with no indication of drug treatment * blood cholesterol levels ranging 250-300 mg/dL * triglycerides (TG) 160-175 mg/dL
Exclusion criteria
* pregnancy * lactation * participation in another supplementary feeding programme
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Days 1 and 30 | In this table the investigators present the weight (kilogram) of the three intervented groups. Data are mean ± sem. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the Body Mass Index of the three intervented groups. Data are mean ± sem. |
| Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Days 1 and 30 | In this table the investigators present the hip/waist ratio of the three intervented groups. Data are mean ± sem. |
| Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the systolic pressure of the three intervented groups. Data are mean ± sem. |
| Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the diastolic pressure of the three intervented groups. Data are mean ± sem. |
| Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the height of the three intervented groups. Data are mean ± sem. |
| Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the cholesterol of the three intervented groups. Data are mean ± sem. |
| Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the Triglycerides (TGs) of the three intervented groups. Data are mean ± sem. |
| Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the Glutamic Pyruvic Transaminase (GPT) of the three intervented groups. Data are mean ± sem. |
| Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Days 1 and 30 | In this table the investigators present the glucose of the three intervented groups. Data are mean ± sem. |
Countries
Spain
Participant flow
Recruitment details
The place where women were recruited for our study was a pharmacy located in the city centre of Elche, during October 2010. Elche is an industrial city located in the Southeast of Spain, with a population of 230 000 inhabitants.
Pre-assignment details
Before the survey began, 14 people were discarded from the survey because their cholesterol levels were lower than the inclusion standards. 5 participants decided to withdraw from the survey once it had began. 3 of them abandoned the study voluntarily. 1 left because she was pregnant, and 1 violated the protocol norms and was expelled.
Participants by arm
| Arm | Count |
|---|---|
| Less Oxidized Oil and Diet Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days. | 17 |
| More Oxidized Oil and Diet Participants from group 2 took 2 capsules/day of one of the most oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days. | 17 |
| Only Diet Participants from group 3 only received the diet. Follow-up 30 days. | 18 |
| Total | 52 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Pregnancy | 0 | 0 | 1 |
| Overall Study | Protocol Violation | 0 | 1 | 0 |
| Overall Study | Withdrawal by Subject | 3 | 0 | 0 |
Baseline characteristics
| Characteristic | More Oxidized Oil and Diet | Only Diet | Less Oxidized Oil and Diet | Total |
|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 4 Participants | 4 Participants | 3 Participants | 11 Participants |
| Age, Categorical Between 18 and 65 years | 13 Participants | 14 Participants | 14 Participants | 41 Participants |
| Age, Continuous | 56.82 years STANDARD_DEVIATION 12.18 | 51.94 years STANDARD_DEVIATION 10.8 | 56.65 years STANDARD_DEVIATION 12.65 | 55.14 years STANDARD_DEVIATION 11.87 |
| Region of Enrollment Spain | 17 participants | 18 participants | 17 participants | 52 participants |
| Sex: Female, Male Female | 17 Participants | 18 Participants | 17 Participants | 52 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 3 / 20 | 0 / 18 | 1 / 19 |
| serious Total, serious adverse events | 0 / 20 | 0 / 18 | 0 / 19 |
Outcome results
Primary
Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)
In this table the investigators present the weight (kilogram) of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 70.17 kilogram | Standard Error 3.71 |
| Less Oxidized Oil and Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 69.38 kilogram | Standard Error 3.61 |
| More Oxidized Oil and Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 68.77 kilogram | Standard Error 3.42 |
| More Oxidized Oil and Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 67.78 kilogram | Standard Error 3.41 |
| Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 75.15 kilogram | Standard Error 3.95 |
| Diet | Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 74.29 kilogram | Standard Error 3.94 |
Secondary
Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the Body Mass Index of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 27.10 kilogram / square metre | Standard Error 1.34 |
| Less Oxidized Oil and Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 27.43 kilogram / square metre | Standard Error 1.41 |
| More Oxidized Oil and Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 26.94 kilogram / square metre | Standard Error 1.36 |
| More Oxidized Oil and Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 28.65 kilogram / square metre | Standard Error 2.13 |
| Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 29.00 kilogram / square metre | Standard Error 1.5 |
| Diet | Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 28.64 kilogram / square metre | Standard Error 1.45 |
Secondary
Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the cholesterol of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 246.64 milligram / decilitre | Standard Error 12.92 |
| Less Oxidized Oil and Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 217.76 milligram / decilitre | Standard Error 8.98 |
| More Oxidized Oil and Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 237.52 milligram / decilitre | Standard Error 7.54 |
| More Oxidized Oil and Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 232.94 milligram / decilitre | Standard Error 12.55 |
| Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 227.22 milligram / decilitre | Standard Error 6.02 |
| Diet | Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 236.78 milligram / decilitre | Standard Error 4.17 |
Secondary
Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the diastolic pressure of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 77.2 millimetres of mercury | Standard Error 0.26 |
| Less Oxidized Oil and Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 68.9 millimetres of mercury | Standard Error 0.21 |
| More Oxidized Oil and Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 73.9 millimetres of mercury | Standard Error 0.34 |
| More Oxidized Oil and Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 75.1 millimetres of mercury | Standard Error 0.29 |
| Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 73.3 millimetres of mercury | Standard Error 0.34 |
| Diet | Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 72.8 millimetres of mercury | Standard Error 0.2 |
Secondary
Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the glucose of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 103.35 milligram / decilitre | Standard Error 3.18 |
| Less Oxidized Oil and Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 116.24 milligram / decilitre | Standard Error 4.3 |
| More Oxidized Oil and Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 108.96 milligram / decilitre | Standard Error 11.11 |
| More Oxidized Oil and Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 111.37 milligram / decilitre | Standard Error 2.46 |
| Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 99.72 milligram / decilitre | Standard Error 4.53 |
| Diet | Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 108.26 milligram / decilitre | Standard Error 2.55 |
Secondary
Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the Glutamic Pyruvic Transaminase (GPT) of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 22.70 Units / litre | Standard Error 2.71 |
| Less Oxidized Oil and Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 20.69 Units / litre | Standard Error 3.34 |
| More Oxidized Oil and Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 24.90 Units / litre | Standard Error 2.96 |
| More Oxidized Oil and Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 18.46 Units / litre | Standard Error 1.62 |
| Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 19.94 Units / litre | Standard Error 2.19 |
| Diet | Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 23.54 Units / litre | Standard Error 3.92 |
Secondary
Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the height of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 1.60 metres | Standard Error 0.02 |
| Less Oxidized Oil and Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 1.60 metres | Standard Error 0.02 |
| More Oxidized Oil and Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 1.59 metres | Standard Error 0.01 |
| More Oxidized Oil and Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 1.59 metres | Standard Error 0.01 |
| Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 1.61 metres | Standard Error 0.01 |
| Diet | Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 1.61 metres | Standard Error 0.01 |
Secondary
Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)
In this table the investigators present the hip/waist ratio of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 86.5 ratio*100 | Standard Error 2.1 |
| Less Oxidized Oil and Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 86.5 ratio*100 | Standard Error 2.1 |
| More Oxidized Oil and Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 87.2 ratio*100 | Standard Error 3 |
| More Oxidized Oil and Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 87.2 ratio*100 | Standard Error 3 |
| Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 1 | 86.0 ratio*100 | Standard Error 2.9 |
| Diet | Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) | Day 30 | 86.0 ratio*100 | Standard Error 2.9 |
Secondary
Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the systolic pressure of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 129.9 millimetres of mercury | Standard Error 0.5 |
| Less Oxidized Oil and Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 118.2 millimetres of mercury | Standard Error 0.42 |
| More Oxidized Oil and Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 123.7 millimetres of mercury | Standard Error 0.66 |
| More Oxidized Oil and Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 120.2 millimetres of mercury | Standard Error 0.41 |
| Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 118.6 millimetres of mercury | Standard Error 0.37 |
| Diet | Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 119.4 millimetres of mercury | Standard Error 0.41 |
Secondary
Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).
In this table the investigators present the Triglycerides (TGs) of the three intervented groups. Data are mean ± sem.
Time frame: Days 1 and 30
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Less Oxidized Oil and Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 164.41 milligram / decilitre | Standard Error 15.43 |
| Less Oxidized Oil and Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 125.52 milligram / decilitre | Standard Error 12.34 |
| More Oxidized Oil and Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 160.41 milligram / decilitre | Standard Error 11.34 |
| More Oxidized Oil and Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 116.88 milligram / decilitre | Standard Error 11.43 |
| Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 1 | 174.83 milligram / decilitre | Standard Error 19.83 |
| Diet | Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30). | Day 30 | 130.04 milligram / decilitre | Standard Error 10.18 |